Arteriosclerosis, Vol 8, 40-45, Copyright © 1988 by American Heart Association
ARTICLES |
AM Ostlund-Lindqvist, P Lindqvist, J Brautigam, G Olsson, G Bondjers and C Nordborg
Department of Pharmacology and Biochemistry, Hassle Research Laboratories, Molndal, Sweden.
The effect of metoprolol, a beta 1-blocker, on atherogenesis was evaluated in rabbits fed a diet supplemented with 0.25% cholesterol and 3% coconut oil for 21 weeks. After 7 weeks on the diet, the rabbits were randomly divided into treated (n = 22) and untreated (n = 22) groups. Treated animals received metoprolol subcutaneously by an osmotic pump for 14 weeks, resulting in a plasma level of 774 +/- 69 nM during the investigation. Plasma concentrations of cholesterol, triglycerides, and phospholipids did not differ between the two groups. Nor were there any significant differences between the two groups in plasma concentrations of apolipoprotein A-I, apolipoprotein B, apolipoprotein C-III, and apolipoprotein E measured by electroimmunoassay. At the end of the study, the aortas were cut into three portions and the extent of atherosclerosis was determined by morphometry. The group that had received metoprolol had significantly (p less than 0.015) less atherosclerosis in the aorta (ascending plus arch 37.8 +/- 6.8%, thoracic 32.9 +/- 6.1%, abdominal 19.8 +/- 6.1% of total intimal area; mean +/- SEM) than the controls (ascending plus arch 54.9 +/- 7.1%, thoracic 48.0 +/- 6.2%, abdominal 25.9 +/- 5.5%).
This article has been cited by other articles:
![]() |
I. Sipahi, E. M. Tuzcu, K. E. Wolski, S. J. Nicholls, P. Schoenhagen, B. Hu, C. Balog, M. Shishehbor, W. A. Magyar, T. D. Crowe, et al. {beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials Ann Intern Med, July 3, 2007; 147(1): 10 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wiklund, J. Hulthe, J. Wikstrand, C. Schmidt, S.-O. Olofsson, and G. Bondjers Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study Stroke, February 1, 2002; 33(2): 572 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hedblad, J. Wikstrand, L. Janzon, H. Wedel, and G. Berglund Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness : Main Results From the {beta}-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) Circulation, April 3, 2001; 103(13): 1721 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wikstrand, I. Warnold, G. Olsson, J. Tuomilehto, D. Elmfeldt, G. Berglund, the Advisory Committee, G. Olsson, J. Tuomilehto, I. Warnold, et al. Primary Prevention With Metoprolol in Patients With Hypertension: Mortality Results From the MAPHY Study JAMA, April 1, 1988; 259(13): 1976 - 1982. [Abstract] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |